Corrigendum to “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms”

In the article titled “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms” [1], the authors mistakenly generated the line graph of Figure 1(c) using the data from Figure 1(b). The corrected figure is provided as follows.

Figure 1.

Cytotoxicity of NAP on human oral keratinocytes, human gingival epithelial cells, and macrophages. (a) Chemical structure of napabucasin; (b) viability of HOK treated with NAP and CHX: IC50_NAP > 62.5 μg/mL and IC50_CHX = 31.25 ~ 62.5 μg/mL; (c) viability of HGE treated with NAP and CHX: IC50_NAP > 62.5 μg/mL and IC50_CHX > 62.5 μg/mL; (d) viability of RAW264.7 treated with NAP and CHX: IC50_NAP > 62.5 μg/mL and IC50_CHX = 31.25 ~ 62.5 μg/mL. HOK: human oral keratinocytes; HGE: human gingival epithelial cells; RAW264.7: macrophages RAW264.7.